Esclerosis sistémica.

dialnet-ar-18-ART0001500865

dialnet

Dialnet

Dialnet AR

RECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 5, Nº. 1 (Número Especial 1), 2021, pags. 91-100

Spanish

Esclerosis
Sistémica
Esclerodermia
Manifestaciones
Generalidades
Sclerosis
Systemic
Scleroderma
Manifestations
Generalities

Esclerosis
Sistémica
Esclerodermia
Manifestaciones
Generalidades
Sclerosis
Systemic
Scleroderma
Manifestations
Generalities
Jaramillo Salazar, Jessica Cecilia
Bonilla Poma, Wendy Cristina
Borja Guzmán, María Eugenia
Macias Sánchez, Yurlendy Elizabeth
Esclerosis sistémica.

One of the consequences of rheumatic diseases throughout the world is the disability of people. These diseases in their chronic stage constitute a considerable social and economic burden in all societies. There are more than a hundred rheumatic diseases, however, among the top ten is scleroderma. Systemic sclerosis is the most serious type of scleroderma, capable of affecting many of the body's systems. Due to its myriad signs and symptoms, its management is an increasing challenge for rheumatologists and physicians in related specialties. The main purpose of this study is to draw an outline about the generalities of Systemic Sclerosis, with emphasis on its main signs and symptoms. The research model is a bibliographic documentary type review. The most common initial symptoms and signs of systemic sclerosis are Raynaud's phenomenon and insidious swelling of the distal extremities with gradual thickening of the skin of the fingers. But it also presents systemic manifestations, mainly affecting the pulmonary, cardiovascular, digestive and renal systems. Systemic sclerosis is a systemic and autoimmune disease, with a rare presence in the population, however, with high morbidity and mortality and a significant decrease in the quality of life of people who suffer from it. It is imperative to recognize its initial clinical manifestations along with both cutaneous and systemic complications, which appear as this disease evolves. Its early diagnosis and prescription of treatment is a determining factor in improving the quality of life of patients.

Article

Jaramillo Salazar, Jessica Cecilia
Bonilla Poma, Wendy Cristina
Borja Guzmán, María Eugenia
Macias Sánchez, Yurlendy Elizabeth

Jaramillo Salazar, Jessica Cecilia
Bonilla Poma, Wendy Cristina
Borja Guzmán, María Eugenia
Macias Sánchez, Yurlendy Elizabeth

Jaramillo Salazar, Jessica Cecilia

Esclerosis sistémica.

Esclerosis sistémica.

Esclerosis sistémica.

Esclerosis sistémica.

Esclerosis sistémica.

esclerosis sistémica.

2021

https://dialnet.unirioja.es/servlet/oaiart?codigo=8215614

1768007479629709312

dialnet-ar-18-ART00015008652023-06-04Esclerosis sistémica.Jaramillo Salazar, Jessica CeciliaBonilla Poma, Wendy CristinaBorja Guzmán, María EugeniaMacias Sánchez, Yurlendy ElizabethEsclerosisSistémicaEsclerodermiaManifestacionesGeneralidadesSclerosisSystemicSclerodermaManifestationsGeneralitiesOne of the consequences of rheumatic diseases throughout the world is the disability of people. These diseases in their chronic stage constitute a considerable social and economic burden in all societies. There are more than a hundred rheumatic diseases, however, among the top ten is scleroderma. Systemic sclerosis is the most serious type of scleroderma, capable of affecting many of the body's systems. Due to its myriad signs and symptoms, its management is an increasing challenge for rheumatologists and physicians in related specialties. The main purpose of this study is to draw an outline about the generalities of Systemic Sclerosis, with emphasis on its main signs and symptoms. The research model is a bibliographic documentary type review. The most common initial symptoms and signs of systemic sclerosis are Raynaud's phenomenon and insidious swelling of the distal extremities with gradual thickening of the skin of the fingers. But it also presents systemic manifestations, mainly affecting the pulmonary, cardiovascular, digestive and renal systems. Systemic sclerosis is a systemic and autoimmune disease, with a rare presence in the population, however, with high morbidity and mortality and a significant decrease in the quality of life of people who suffer from it. It is imperative to recognize its initial clinical manifestations along with both cutaneous and systemic complications, which appear as this disease evolves. Its early diagnosis and prescription of treatment is a determining factor in improving the quality of life of patients.Una de las consecuencias de las enfermedades reumáticas en todo el mundo es la incapacidad de las personas. Estas enfermedades en su etapa crónica constituyen una carga social y económica considerable en todas las sociedades. Existen más de cien enfermedades reumáticas, no obstante, entre las diez principales se encuentra la esclerodermia. La esclerosis sistémica es el tipo de esclerodermia más grave, capaz de afectar a muchos de los sistemas del cuerpo. Por sus innumerables signos y síntomas, su manejo es un desafío cada vez mayor para los reumatólogos y los médicos de especialidades relacionadas. El propósito fundamental del presente estudio consiste en plasmar un esbozo acerca de las generalidades de la Esclerosis Sistémica, con énfasis en sus principales signos y síntomas. El modelo de investigación es una revisión de tipo documental bibliográfico. Los síntomas y signos iniciales más frecuentes de la esclerosis sistémica son el fenómeno de Raynaud y la hinchazón insidiosa de las extremidades distales con engrosamiento gradual de la piel de los dedos. Pero presenta además manifestaciones sistémicas, afectando principalmente el sistema pulmonar, cardiovascular, digestivo y renal. La esclerosis sistémica es una enfermedad sistémica y autoinmune, con una presencia poco frecuente en la población, no obstante, con alta morbimortalidad y disminución importante de la calidad de vida de las personas que la padecen. Es imperioso reconocer sus manifestaciones clínicas iniciales a la par con las complicaciones tanto cutáneas como sistémicas, que se presenten a medida que esta enfermedad evoluciona. Su diagnóstico y la prescripción de un tratamiento de manera temprana es un factor determinante en la mejora de la calidad de vida de los pacientes.2021text (article)application/pdfhttps://dialnet.unirioja.es/servlet/oaiart?codigo=8215614(Revista) ISSN 2588-073XRECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 5, Nº. 1 (Número Especial 1), 2021, pags. 91-100spaLICENCIA DE USO: Los documentos a texto completo incluidos en Dialnet son de acceso libre y propiedad de sus autores y/o editores. Por tanto, cualquier acto de reproducción, distribución, comunicación pública y/o transformación total o parcial requiere el consentimiento expreso y escrito de aquéllos. Cualquier enlace al texto completo de estos documentos deberá hacerse a través de la URL oficial de éstos en Dialnet. Más información: https://dialnet.unirioja.es/info/derechosOAI | INTELLECTUAL PROPERTY RIGHTS STATEMENT: Full text documents hosted by Dialnet are protected by copyright and/or related rights. This digital object is accessible without charge, but its use is subject to the licensing conditions set by its authors or editors. Unless expressly stated otherwise in the licensing conditions, you are free to linking, browsing, printing and making a copy for your own personal purposes. All other acts of reproduction and communication to the public are subject to the licensing conditions expressed by editors and authors and require consent from them. Any link to this document should be made using its official URL in Dialnet. More info: https://dialnet.unirioja.es/info/derechosOAI